Belgium is increasingly recognized as a leading destination for advanced cancer and blood disorder care due to its strong medical infrastructure and world-class specialists. Many patients seek the Best Onco-Hematologists in Belgium because the country combines high clinical standards, advanced therapies, and integrated oncology-hematology approaches that ensure precise treatment outcomes.
The demand for expert onco-hematology care is growing among both local and international patients. Modern Belgium onco-hematology clinics are equipped with advanced technologies such as targeted immunotherapies, precision diagnostics, and access to clinical trials. Many of the internationally trained onco-hematologists have studied or practiced abroad, ensuring that treatment in Belgium aligns with global protocols while remaining patient-focused.
Cost efficiency is another factor attracting medical tourists. Belgium offers treatment packages that are significantly more affordable compared with neighboring Western European countries without compromising quality. National health policies emphasize equitable access and safety standards, guided by both the Ministry of Health and professional bodies. Patients can also explore official guidance through the World Health Organization Belgium profile, which provides insights into national healthcare quality and standards.
Belgium’s health system is also monitored and regulated through the Federal Public Service Health, offering transparent information about specialist accreditation, hospital performance, and patient rights. With this combination of skilled professionals, advanced technology, and balanced pricing, Belgium continues to strengthen its position as a trusted hub for complex cancer and hematology treatments. In the next section, we introduce the Top Onco-Hematologists in Belgium, highlighting their expertise and areas of specialization.
Prof. Daan Dierickx
Specialization: Lymphoid malignancies, clinical trials, and translational hematology
Experience: 15+ years (since 2010)
Prof. Daan Dierickx is a senior haematologist at UZ Leuven and head of the Laboratory of Experimental Hematology. He leads clinical trials in lymphoma and chronic lymphocytic leukemia with a translational focus on targeted and immune therapies. Internationally trained and widely published, he combines trial leadership with hands-on patient care and multidisciplinary tumour boards, making him a frequently consulted onco-hematologist in Leuven.
Prof. Ann Janssens
Specialization: Clinical hematology (acute leukemias and complex blood disorders)
Experience: 28+ years (since 1996)
Prof. Ann Janssens is a senior haematologist at UZ Leuven with extensive clinical and academic experience. She works on acute leukemias, diagnostic hematopathology, and translational research while contributing to guideline development. Her combination of research depth and routine clinical practice ensures evidence-based care for both local and international patients in Belgium.
Prof. Nathalie Meuleman
Specialization: Lymphoid malignancies, cellular therapy, and transplant medicine
Experience: 15+ years (since 2008)
Prof. Nathalie Meuleman leads the Hematology Department at Institut Jules Bordet in Brussels. She manages lymphoid malignancies and cellular therapy programs, coordinating complex cases and transplant referrals. Active in European research networks, she routinely oversees multidisciplinary treatment plans for local and international patients.
Dr. Fulvio Massaro
Specialization: Lymphoproliferative disorders and cell therapy
Experience: 12+ years (since 2011)
Dr. Fulvio Massaro works in the Hematology unit at Institut Jules Bordet, focusing on lymphomas and related disorders. He participates in protocol development for targeted agents and emerging immunotherapies. His clinical interests in cell therapy enhance diagnostic precision and access to cutting-edge treatments.
Dr. Nicolas Kint
Specialization: Plasma cell disorders, multiple myeloma, and AL amyloidosis
Experience: 10+ years (since 2013)
Dr. Nicolas Kint is a clinical hematologist at Ghent University Hospital (UZ Gent) with expertise in myeloma and related plasma cell diseases. Engaged in translational research and personalized therapeutic strategies, he is frequently consulted for complex myeloma cases.
Prof. Michel Delforge
Specialization: Hematological malignancies, multiple myeloma, and translational hematology
Experience: 35+ years (since 1988)
Prof. Michel Delforge is a long-established haematology professor at UZ Leuven with decades of clinical, research, and teaching experience. He leads research programs, supervises clinical fellows, and contributes to national and international guideline committees, serving as a key referral clinician for relapsed or refractory hematologic diseases.
Consultation | Cost in USD |
Consultation with an Onco-Hematologist | $ 250 |
Note: The cost of consulting an onco-hematologist in Belgium can vary depending on several factors. These include the specialist’s experience and international training, whether the consultation is at a private practice or university hospital, and the need for additional diagnostics such as blood tests, bone marrow analysis, or advanced imaging. The complexity of the hematologic condition and the hospital location also influence pricing. Guidelines from the European Hematology Association provide internationally recognized standards for hematology care, helping patients understand treatment expectations and quality assurance.
➤ High-quality treatment delivered in line with Belgium’s national Ministry of Health standards.
➤ Affordable onco-hematology care compared with the United States and neighboring Western European countries.
➤ Internationally trained onco-hematologists with strong academic and research backgrounds.
➤ Access to advanced diagnostic tools, targeted therapies, and bone marrow transplantation.
➤ English-speaking doctors and staff ensure smooth communication for international patients in Belgium.
➤ Strong support services, including counseling and follow-up care tailored to cancer and blood disorders.
➤ Professional guidance from the Belgian Society for Medical Oncology ensures best practices and clinical oversight.
➤ Opportunity to combine treatment with recovery in Belgium’s calm, scenic regions.